Researchers tested whether vitamin D could protect rat kidneys from damage caused by cisplatin, a common chemotherapy drug. They gave one group of rats cisplatin alone, while another group received cisplatin plus vitamin D supplements. The vitamin D group showed significantly less kidney damage and lower levels of harmful molecules that damage cells. While these results are promising and suggest vitamin D might help protect kidneys during cancer treatment, the study was done in rats, so more research in humans is needed before doctors can recommend this approach to patients.
The Quick Take
- What they studied: Whether taking vitamin D supplements could reduce kidney damage caused by cisplatin, a chemotherapy drug used to treat cancer
- Who participated: 21 female laboratory rats, about 6 months old, divided into three groups: a control group, a group receiving cisplatin only, and a group receiving both cisplatin and vitamin D
- Key finding: Rats that received vitamin D along with cisplatin had significantly less kidney damage and lower levels of harmful cell-damaging molecules compared to rats that received cisplatin alone
- What it means for you: This research suggests vitamin D might help protect kidneys during chemotherapy, but these results are from animal studies. People undergoing cancer treatment should not change their vitamin D intake without talking to their doctor first, as more human studies are needed to confirm safety and effectiveness
The Research Details
Scientists divided 21 female rats into three equal groups of seven rats each. The first group (control) received salt water injections for 7 days to establish a baseline. The second group received a single dose of cisplatin chemotherapy on day 1. The third group received the same cisplatin dose on day 1, then received vitamin D injections daily for the next 7 days. After the experiment ended, researchers examined the rats’ kidney tissue under a microscope and tested for specific proteins and markers of cell damage to compare how much harm each group experienced.
This research approach is important because it allowed scientists to carefully control all variables and directly observe how vitamin D affects kidney damage at the cellular level. By using identical animals and measuring multiple markers of kidney health, the researchers could determine whether vitamin D truly protects kidneys or if the results happened by chance. This type of controlled animal study is a necessary step before testing treatments in humans.
This study has several strengths: it used a control group for comparison, randomly assigned animals to groups, and measured multiple markers of kidney damage rather than relying on just one test. However, the study was conducted in rats, not humans, so results may not apply directly to people. The sample size was relatively small (21 animals total), and the study was published in 2026, so it represents recent research. Readers should note this is preliminary evidence that requires human studies before clinical recommendations can be made.
What the Results Show
Cisplatin chemotherapy caused significant kidney damage in rats, as shown by increased levels of harmful molecules (oxidative stress) and visible damage to kidney tubules (the tiny filtering units in kidneys) when examined under a microscope. When vitamin D was added to the treatment, the amount of harmful molecules decreased substantially, and the kidney damage was much less severe. The difference between the cisplatin-only group and the cisplatin-plus-vitamin-D group was statistically significant, meaning the results were unlikely to have occurred by chance. Additionally, vitamin D reduced the activity of several proteins that indicate cellular stress and damage, suggesting the vitamin worked at a molecular level to protect kidney cells.
The study measured five specific proteins involved in cell damage and protection. In the cisplatin-only group, all five proteins were elevated, indicating the kidneys were under severe stress. In the vitamin D group, levels of these stress proteins were significantly lower, suggesting vitamin D helped cells maintain better health. The researchers also found that vitamin D appeared to activate the kidney’s natural defense systems, helping cells repair themselves and remove damaged components more effectively.
Previous research has shown that cisplatin damages kidneys by creating harmful molecules called free radicals that overwhelm the body’s natural defense systems. Vitamin D is known to have antioxidant properties (meaning it can neutralize harmful molecules) and to support the body’s natural repair mechanisms. This study builds on that existing knowledge by demonstrating that vitamin D’s protective effects appear to work through specific cellular pathways. The findings align with earlier research suggesting vitamin D has kidney-protective properties, but this is one of the first studies to examine this effect specifically during chemotherapy.
The most important limitation is that this research was conducted in rats, not humans. Rat biology differs from human biology in important ways, so results may not translate directly to people. The study used only female rats, so it’s unclear whether the findings apply equally to males. The vitamin D dose used (1000 IU daily) may not be equivalent to typical human supplementation doses. The study lasted only 7 days, so it doesn’t show whether vitamin D protection continues over longer periods of chemotherapy. Finally, the study didn’t examine potential side effects or interactions with other medications that cancer patients typically take.
The Bottom Line
Based on this animal study, vitamin D supplementation during cisplatin chemotherapy appears promising for kidney protection (moderate confidence level). However, because this research was conducted in rats, it cannot yet be recommended for human patients. Anyone undergoing cisplatin chemotherapy should discuss vitamin D supplementation with their oncologist before starting any new supplements, as the appropriate dose and safety in humans remain unclear.
This research is most relevant to cancer patients receiving cisplatin chemotherapy and their doctors, as kidney damage is a known side effect of this drug. Patients with existing kidney problems should be especially interested, as they face higher risk of severe damage. However, this study is preliminary, so patients should not make treatment decisions based solely on these findings. People taking cisplatin for reasons other than cancer (such as certain infections) may also benefit from future research on this topic.
In this rat study, kidney protection from vitamin D was observed within 7 days of starting supplementation. In humans, if vitamin D proves protective, benefits would likely develop gradually over weeks to months of treatment. However, the actual timeline in human patients remains unknown and would require clinical studies to determine. Patients should not expect immediate results and should maintain regular kidney function monitoring as recommended by their healthcare team.
Want to Apply This Research?
- If a user is undergoing cisplatin chemotherapy and their doctor approves vitamin D supplementation, track daily vitamin D intake (in IU), kidney function markers from blood tests (creatinine and BUN levels), and any symptoms of kidney problems such as changes in urination, swelling, or fatigue
- Users could set daily reminders to take vitamin D supplements at the same time each day if approved by their doctor, log their supplement intake in the app, and record any side effects or changes in how they feel. The app could provide educational content about kidney health during chemotherapy and prompt users to schedule regular kidney function tests
- Establish a long-term tracking system that monitors vitamin D supplementation compliance, documents kidney function test results from doctor visits, tracks symptoms related to kidney health, and allows users to share this information with their healthcare team. The app could generate reports showing trends in kidney function over the course of chemotherapy treatment
This research was conducted in laboratory rats and has not been tested in humans. Vitamin D supplementation during chemotherapy should only be considered under direct medical supervision. Do not start, stop, or change vitamin D supplements without consulting your oncologist or healthcare provider, as supplements can interact with chemotherapy drugs and other medications. Kidney function should be monitored regularly during cisplatin treatment through blood tests ordered by your medical team. This article is for educational purposes only and does not constitute medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.